Works matching IS 14642662 AND DT 2018 AND VI 19 AND IP 3

Results: 11

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. 227, doi. 10.1111/hiv.12571

By:

Rosenthal, E.;
Fougerou‐Leurent, C.;
Renault, A.;
Carrieri, M. P.;
Marcellin, F.;
Garraffo, R.;
Teicher, E.;
Aumaitre, H.;
Lacombe, K.;
Bailly, F.;
Billaud, E.;
Chevaliez, S.;
Dominguez, S.;
Valantin, M. A.;
Reynes, J.;
Naqvi, A.;
Cotte, L.;
Metivier, S.;
Leroy, V.;
Dupon, M.

Publication type:

Article

Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. 216, doi. 10.1111/hiv.12570

By:

Smolders, E. J.;
Smit, C.;
de Kanter, C. T. M. M.;
Dofferhoff, A. S. M.;
Arends, J. E.;
Brinkman, K.;
Rijnders, B.;
van der Valk, M.;
Reiss, P.;
Burger, D. M.;
the ATHENA National HIV Observational Cohort

Publication type:

Article

HbAHP‐25 attenuates HIV‐1 gp120 mediated inflammation and barrier dysfunction.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. 206, doi. 10.1111/hiv.12569

By:

Bashir, T.;
Reddy, K. V. R.

Publication type:

Article

Hospital‐based routine HIV testing in high‐income countries: a systematic literature review.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. 195, doi. 10.1111/hiv.12568

By:

Elgalib, A.;
Fidler, S.;
Sabapathy, K.

Publication type:

Article

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. 184, doi. 10.1111/hiv.12567

By:

Stirrup, O. T.;
Copas, A. J.;
Phillips, A. N.;
Gill, M. J.;
Geskus, R. B.;
Touloumi, G.;
Young, J.;
Bucher, H. C.;
Babiker, A. G.;
CASCADE Collaboration in EuroCoord

Publication type:

Article

Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. 175, doi. 10.1111/hiv.12566

By:

Jao, J.;
Yu, W.;
Patel, K.;
Miller, T. L.;
Karalius, B.;
Geffner, M. E.;
DiMeglio, L. A.;
Mirza, A.;
Chen, J. S.;
Silio, M.;
McFarland, E. J.;
Van Dyke, R. B.;
Jacobson, D.;
the Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) study

Publication type:

Article

Issue Information.

Published in:: HIV Medicine, 2018, v. 19, n. 3, p. 1, doi. 10.1111/hiv.12549
Publication type:: Article

No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. 238, doi. 10.1111/hiv.12545

By:

Cuzin, L.;
Yazdanpanah, Y.;
Huleux, T.;
Cotte, L.;
Pugliese, P.;
Allavena, C.;
Reynes, J.;
Poizot‐Martin, I.;
Bani‐Sadr, F.;
Delpierre, C.;
the Dat'AIDS Study Group

Publication type:

Article

HIV testing in persons diagnosed with hepatitis B and C.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. e54, doi. 10.1111/hiv.12525

By:

Ireland, G.;
Ogaz, D.;
Kirwan, P.;
Mandal, S.;
Delpech, V.;
Connor, N.;
Simmons, R.

Publication type:

Article

Now is the Time to Study the Timing of Influenza Vaccine.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. e53, doi. 10.1111/hiv.12486

By:

Glinka, E. R.;
Smith, D. M.;
Johns, S. T.

Publication type:

Article

Response to Glinka <italic>et al</italic>. “Timing matters ‐ influenza vaccination to HIV‐infected patients”.

Published in:

HIV Medicine, 2018, v. 19, n. 3, p. e52, doi. 10.1111/hiv.12485

By:

Williams, C.

Publication type:

Article